【close】COVID-19 Webinar #3 "COVID-19 Case Management In Japan"


event |


Moderators and panelists

Prof. KATO Yasuyuki (MD, MPH, Professor of infectious diseases, School of Medicine, International University of Health and Welfare, Japan)

Dr. ISONO Mitsuo (Senior Advisor, Human Development Department, JICA)

Ms. MAKIMOTO Saeda (Principal Research Fellow, JICA Ogata Sadako Research Institute for Peace and Development)

Primary objectives and outcomes

The end of the COVID-19 pandemic is still not in sight. To overcome the challenges in times of uncertainty, Japan set the goal of "leaving no one's health behind". JICA is taking a holistic approach to addressing the pandemic and health security in our partner LMICs by focusing on prevention, precaution and treatment. By using this approach, we hope to contribute to the protection of people's lives as the urgent target and build more resilient societies.

In a situation where we don't have the right solution yet, it is imperative to continuously share the latest research findings, as well as practical knowledge and experience gained through practice. The aim of this webinar is to invite distinguished Japanese researchers and clinicians to share their latest knowledge and experience in their respective fields, and to promote each country's efforts in protecting people's lives from COVID-19.

Content of the discussions

Prof. KATO is a board member/preparation group member for "Clinical Management of Patients with COVID-19: A guide for front-line healthcare workers" supported by Ministry of Health, Labour and Welfare, Japan. He introduced various case management practices in Japan, including testing and diagnostic methods, management of severe/critically ill patients, pharmacotherapy, and home-based care, based on the discussion in the process of drafting and revising the guide.

The webinar was joined by 411 participants from 62 countries around the world. During the Q&A session, lots of burning questions were raised: the use of antigen-based rapid diagnostic testing as a definitive diagnosis, case management for moderate cases, drug therapy for which clinical trials are still ongoing. Finally Prof. KATO emphasised the importance of identifying risk factors for severe diseases in order to prevent death,especially in elderly people, introducing antigen-based rapid diagnostic testing, and distributing pulseoximeters widely to monitor high risk patients in resource-limited settings.

Related Experts